These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 8706359)

  • 21. Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection.
    Sorkhi H; Roushan MR; Al Hashemi GH; Dooki MR; Bai S
    East Mediterr Health J; 2008; 14(4):798-803. PubMed ID: 19166162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and long-term immunogenicity of hepatitis B vaccine in haemodialysis patients.
    Ramezani A; Eslamifar A; Banifazl M; Ahmadi F; Maziar S; Razeghi E; Kalantar E; Amirkhani A; Aghakhani A
    Int J Clin Pract; 2009 Mar; 63(3):394-7. PubMed ID: 18005039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
    Jafarzadeh A; Zarei S; Shokri F
    Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
    Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
    Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy of prophylactic vaccination against Hepatitis B Virus infection viruses in hemodialyzed patients].
    Urbanowicz W
    Przegl Epidemiol; 2000; 54(3-4):343-50. PubMed ID: 11349597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistence of hepatitis B vaccine immunity in hemodialysis patients.
    Ramezani A; Velayati AA; Eslamifar A; Banifazl M; Ahmadi F; Maziar S; Razeghi E; Kalantar E; Amirkhani A; Aghakhani A
    Ther Apher Dial; 2008 Apr; 12(2):143-6. PubMed ID: 18387163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
    Jafarzadeh A; Montazerifar SJ
    J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Revaccination against hepatitis B in non-responders and in under-responders in a group of mentally handicapped patients].
    Vermeltfoort JA
    Ned Tijdschr Geneeskd; 1991 Nov; 135(46):2173-5. PubMed ID: 1835517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low response to HBsAg vaccine in chronic renal failure patients is not due to intrinsic defect of B cells.
    Krishnamurthy G; Kher V; Naik S
    Scand J Urol Nephrol; 2002; 36(5):377-82. PubMed ID: 12487744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of vaccine potency against viral hepatitis B performed with HB-vax II vaccine in a group with an increased risk for hepatitis B].
    Leśnik J; Cieślak A; Krychniak E; Sitkiewicz D
    Pol Merkur Lekarski; 1996 Oct; 1(4):249-51. PubMed ID: 9156936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes.
    Halota W; Muszyńska M; Pawłowska M
    Med Sci Monit; 2002 Jul; 8(7):CR516-9. PubMed ID: 12118201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease.
    Lacson E; Teng M; Ong J; Vienneau L; Ofsthun N; Lazarus JM
    Hemodial Int; 2005 Oct; 9(4):367-75. PubMed ID: 16219057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C.
    Idilman R; De MN; Colantoni A; Nadir A; Van Thiel DH
    Am J Gastroenterol; 2002 Feb; 97(2):435-9. PubMed ID: 11866284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vaccination against Hepatitis B Virus in chronic renal disease patients].
    Franco E; Senatore S; Ruggiero F; Papa R; Zaratti L
    Ig Sanita Pubbl; 2008 Jan; 64(1):131-6. PubMed ID: 18379610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody level after hepatitis B vaccination in hemodialysis patients: influence of hepatitis C virus infection.
    Navarro JF; Teruel JL; Mateos ML; Marcen R; Ortuno J
    Am J Nephrol; 1996; 16(2):95-7. PubMed ID: 8919223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extra-high-dose hepatitis B vaccination does not confer longer serological protection in peritoneal dialysis patients: a randomized controlled trial.
    Chow KM; Lo SH; Szeto CC; Yuen SK; Wong KS; Kwan BC; Leung CB; Li PK
    Nephrol Dial Transplant; 2010 Jul; 25(7):2303-9. PubMed ID: 20185409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Normal response to anti-HBV vaccination in children with chronic renal insufficiency.
    La Manna A; Polito C; Foglia AC; Opallo A; Cafaro MR; Di Toro R
    Child Nephrol Urol; 1991; 11(4):203-5. PubMed ID: 1838031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The significance of immunocompromised condition in the prophylaxis of hepatitis B in chronic renal insufficiency.
    Gasparović V; Puljević D; Gjurasin M; Delimar N; Borcić D; Gasparović H; Mihaljević I
    Acta Med Croatica; 1993; 47(2):61-5. PubMed ID: 7505130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Transient blood surface antigens of hepatitis B in patients on hemodialysis].
    Santana Rodríguez OE; Morillas Jarillo C; Esparza Martín N; Toledo González A; Checa Andrés MD; Martín Sánchez AM
    Rev Clin Esp; 1999 Apr; 199(4):198-201. PubMed ID: 10364790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.